Paul Hergenrother
0000-0001-9018-3581
5 papers found
Refreshing results…
A Gram-negative-selective antibiotic that spares the gut microbiome
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections
Rationalizing the generation of broad spectrum antibiotics with the addition of a positive charge
Gram-Negative Antibiotic Active Through Inhibition of an Essential Riboswitch
Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogens
Missing publications? Search for publications with a matching author name.